footnotes

[1]“Plan B One-Step Prescribing Information: Mechanism of Action,” Barr Pharmaceuticals, last modified August 2009, http://www.planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf

[2]“Plan B One-Step Prescribing Information: Indications and Usage,” Barr Pharmaceuticals, last modified August 2009, http://www.planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf

[3]“Plan B One-Step Prescribing Information: Clinical Trials Experience,” Barr Pharmaceuticals, last modified August 2009, http://www.planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf

[4]“Plan B One-Step Prescribing Information: Contraindications,” Barr Pharmaceuticals, last modified August 2009, http://www.planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf and “Plan B One-Step Prescribing Information: Indications and Usage,” Barr Pharmaceuticals, last modified August 2009, http://www.planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf

[5]“Plan B One-Step Prescribing Information: Ectopic Pregnancy,” Barr Pharmaceuticals, last modified August 2009, http://www.planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf

[6]“Plan B One-Step Prescribing Information: Clinical Studies,” Barr Pharmaceuticals, last modified August 2009, http://www.planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf

[7]“Plan B One-Step Prescribing Information: Drug Abuse and Dependence,” Barr Pharmaceuticals, last modified August 2009, http://www.planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf

[8]“Plan B One-Step Prescribing Information: Overdose,” Barr Pharmaceuticals, last modified August 2009, http://www.planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf

[9]“Plan B One-Step Prescribing Information: Specific Populations/Pediatric,” Barr Pharmaceuticals, last modified August 2009, http://www.planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf

[10]“Plan B One-Step Prescribing Information: Specific Populations/Geriatric,” Barr Pharmaceuticals, last modified August 2009, http://www.planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf

[11]“Plan B One-Step Prescribing Information: Specific Populations/Hepatic Impairment,” Barr Pharmaceuticals, last modified August 2009, http://www.planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf

[12]“Plan B One-Step Prescribing Information: Specific Populations/Renal Impairment,” Barr Pharmaceuticals, last modified August 2009, http://www.planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf

[13]“Plan B One-Step Prescribing Information: Drug-Drug Interactions,” Barr Pharmaceuticals, last modified August 2009, http://www.planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf

[14]“Plan B One-Step Prescribing Information: Specific Populations/Race,” Barr Pharmaceuticals, last modified August 2009, http://www.planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf

[15]“ella Prescribing Information: Open-Label Study,” Watson Pharma, last modified April 2012, http://pi.watson.com/data_stream.asp?product_group=1699&p=pi&language=E

[16]“ella Prescribing Information: Mechanism of Action,” Watson Pharma, last modified April 2012, http://pi.watson.com/data_stream.asp?product_group=1699&p=pi&language=E

[17]Donna J. Harrison and James G. Mitroka, “Defining Reality: The Potential Role of Pharmacists in Assessing the Impact of Progesterone Receptor Modulators and Misoprostol in Reproductive Health,” The Annals of Pharmacotherapy 45, (January 2011): 115.

[18]Ibid.

[19]“ella Prescribing Information: Adverse Reactions,” Watson Pharma, last modified April 2012, http://pi.watson.com/data_stream.asp?product_group=1699&p=pi&language=E

[20]“ella Prescribing Information: Open-Label Study,” Watson Pharma, last modified April 2012, http://pi.watson.com/data_stream.asp?product_group=1699&p=pi&language=E

[21]“ella Prescribing Information: Fertility Following Use,” Watson Pharma, last modified April 2012, http://pi.watson.com/data_stream.asp?product_group=1699&p=pi&language=E

[22]“ella Prescribing Information: Contraindications,” Watson Pharma, last modified April 2012, http://pi.watson.com/data_stream.asp?product_group=1699&p=pi&language=E

[23]“ella Prescribing Information: Repeated Use,” Watson Pharma, last modified April 2012, http://pi.watson.com/data_stream.asp?product_group=1699&p=pi&language=E

[24]“ella Prescribing Information: Nursing Mothers,” Watson Pharma, last modified April 2012, http://pi.watson.com/data_stream.asp?product_group=1699&p=pi&language=E

[24]“ella Prescribing Information: Nursing Mothers,” Watson Pharma, last modified April 2012, http://pi.watson.com/data_stream.asp?product_group=1699&p=pi&language=E